Haematology 2018

The future of immunoregulation in lymphoma

• The immune explosion in oncology – ICI, CAR-T cells • Combinatorial immensity • Too big to fail • Too big (and costly) to succeed? Trial Academia

Funding Sources

– Study design – Collaboration – Biomarker driven – Further scientific discovery required

Patients

Science

Samples

Pharma